WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (88)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adlkofer, K.
Right arrow Articles by Suter, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adlkofer, K.
Right arrow Articles by Suter, U.

 Previous Article  |  Next Article 

Volume 17, Number 12, Issue of June 15, 1997 pp. 4662-4671
Copyright ©1997 Society for Neuroscience

Heterozygous Peripheral Myelin Protein 22-Deficient Mice Are Affected by a Progressive Demyelinating Tomaculous Neuropathy

Received Feb. 24, 1997; revised March 18, 1997; accepted April 8, 1997.

Katrin Adlkofer1, Regula Frei1, Dirk H.-H. Neuberg1, Jürgen Zielasek2, Klaus V. Toyka2, and Ueli Suter1

1 Institute of Cell Biology, Department of Biology, Swiss Federal Institute of Technology, CH-8093 Zürich, Switzerland, and 2 Department of Neurology, Julius-Maximilians-University, D-97080 Würzburg, Germany

Hereditary neuropathy with liability to pressure palsy (HNPP) is associated with a heterozygous 1.5 megabase deletion on chromosome 17 that includes the peripheral myelin protein (PMP) gene PMP22. We show that heterozygous PMP22 knock-out mice, which carry only one functional pmp22 allele and thus genetically mimic HNPP closely, display similar morphological and electrophysiological features as observed in HNPP nerves. As reported previously, focal hypermyelinating structures called tomacula, the pathological hallmarks of HNPP, develop progressively in young PMP22+/0 mice. By following the fate of tomacula during aging, we demonstrate now that these mutant animals are also interesting models for examining HNPP disease mechanisms. Subtle electrophysiological abnormalities are detected in PMP22+/0 mice >1 year old, and a significant number of abnormally swollen and degenerating tomacula are present. Thinly myelinated axons and supernumerary Schwann cells forming onion bulbs as fingerprints of repeated cycles of demyelination and remyelination are also encountered frequently. Quantitative analyses using electron microscopy on cross sections and light microscopy on single teased nerve fibers suggest that tomacula are intrinsically unstable structures that are prone to degeneration; however, the severity of morphological and electrophysiological abnormalities in PMP22+/0 mice is variable. These combined findings are reminiscent of the disease progression in HNPP and offer a possible explanation about why some HNPP patients develop a chronic motor and sensory neuropathy later in life that resembles demyelinating forms of Charcot-Marie-Tooth disease by both morphological and clinical criteria.

Key words: PMP22; peripheral myelin protein-22; peripheral neuropathy; myelin; Charcot-Marie-Tooth disease; CMT; hereditary neuropathy with liability to pressure palsies; HNPP; tomaculous neuropathy; demyelination




This article has been cited by other articles:


Home page
Arch NeurolHome page
J. Li, K. Ghandour, D. Radovanovic, R. R. Shy, K. M. Krajewski, M. E. Shy, and G. A. Nicholson
Stoichiometric Alteration of PMP22 Protein Determines the Phenotype of Hereditary Neuropathy With Liability to Pressure Palsies
Arch Neurol, July 1, 2007; 64(7): 974 - 978.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
Z. Cai, J. W. Finnie, and P. C. Blumbergs
Avian riboflavin deficiency: an acquired tomaculous neuropathy.
Vet. Pathol., September 1, 2006; 43(5): 780 - 781.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. A. Amici, W. A. Dunn Jr, A. J. Murphy, N. C. Adams, N. W. Gale, D. M. Valenzuela, G. D. Yancopoulos, and L. Notterpek
Peripheral Myelin Protein 22 Is in Complex with {alpha}6beta4 Integrin, and Its Absence Alters the Schwann Cell Basal Lamina
J. Neurosci., January 25, 2006; 26(4): 1179 - 1189.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
A. E. Runker, I. Kobsar, T. Fink, G. Loers, T. Tilling, P. Putthoff, C. Wessig, R. Martini, and M. Schachner
Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder
J. Cell Biol., May 24, 2004; 165(4): 565 - 573.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Sancho, P. Young, and U. Suter
Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A
Brain, November 1, 2001; 124(11): 2177 - 2187.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. C. Previtali, A. Quattrini, M. Fasolini, M. C. Panzeri, A. Villa, M. T. Filbin, W. Li, S.-Y. Chiu, A. Messing, L. Wrabetz, et al.
Epitope-Tagged P0Glycoprotein Causes Charcot-Marie-Tooth-Like Neuropathy in Transgenic Mice
J. Cell Biol., November 27, 2000; 151(5): 1035 - 1046.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Niemann, M. W. Sereda, U. Suter, I. R. Griffiths, and K.-A. Nave
Uncoupling of Myelin Assembly and Schwann Cell Differentiation by Transgenic Overexpression of Peripheral Myelin Protein 22
J. Neurosci., June 1, 2000; 20(11): 4120 - 4128.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
F. Stogbauer, P. Young, G. Kuhlenbaumer, P. De Jonghe, and V. Timmerman
Hereditary recurrent focal neuropathies: Clinical and molecular features
Neurology, February 8, 2000; 54(3): 546 - 546.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. Kamholz, D. Menichella, A. Jani, J. Garbern, R. A. Lewis, K. M. Krajewski, J. Lilien, S. S. Scherer, and M. E. Shy
Charcot-Marie-Tooth disease type 1: Molecular pathogenesis to gene therapy
Brain, February 1, 2000; 123(2): 222 - 233.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Sancho, J. P. Magyar, A. Aguzzi, and U. Suter1
Distal axonopathy in peripheral nerves of PMP22-mutant mice
Brain, August 1, 1999; 122(8): 1563 - 1577.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. D'Urso, P. Ehrhardt, and H. W. Muller
Peripheral Myelin Protein 22 and Protein Zero: a Novel Association in Peripheral Nervous System Myelin
J. Neurosci., May 1, 1999; 19(9): 3396 - 3403.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. R. Tobler, L. Notterpek, R. Naef, V. Taylor, U. Suter, and E. M. Shooter
Transport of Trembler-J Mutant Peripheral Myelin Protein 22 Is Blocked in the Intermediate Compartment and Affects the Transport of the Wild-Type Protein by Direct Interaction
J. Neurosci., March 15, 1999; 19(6): 2027 - 2036.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
X. Yin, T. O. Crawford, J. W. Griffin, P.-h. Tu, V. M.-Y. Lee, C. Li, J. Roder, and B. D. Trapp
Myelin-Associated Glycoprotein Is a Myelin Signal that Modulates the Caliber of Myelinated Axons
J. Neurosci., March 15, 1998; 18(6): 1953 - 1962.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. R. Tobler, N. Liu, L. Mueller, and E. M. Shooter
Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22
PNAS, January 8, 2002; 99(1): 483 - 488.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-